Why is Windlas Biotech falling/rising?

As of 23-Jul, Windlas Biotech Ltd's stock price is currently at 927.40, reflecting an increase of 10.75 (1.17%). The stock has shown a trend reversal by gaining after four consecutive days of decline, and it outperformed its sector by 0.66%. Despite this positive movement today, the stock has experienced a -1.86% decline over the past week, although it has risen by 5.75% in the last month. The stock is trading at a premium compared to its peers, with a fair valuation indicated by a Price to Book Value of 3.8. However, it has a low Debt to Equity ratio and has generated a return of 35.10% over the past year, despite a modest profit increase of 4.8%. The stock's liquidity remains adequate, but there has been a notable decrease in investor participation, with delivery volume falling by 9.82% against the five-day average.
In the broader market context, Windlas Biotech's recent performance contrasts with the benchmark Sensex, which has gained 0.11% over the past week and 1.01% over the past month. While the stock has outperformed the benchmark over the last year and three years, its year-to-date performance shows a significant decline of -10.26% compared to the Sensex's increase of 5.87%. This indicates that while the stock has had strong historical returns, its recent struggles may be contributing to a cautious outlook among investors, particularly in light of flat results reported in March and concerns over long-term growth potential.